Scientific article
Case report
English

Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A

Published in

Acta ophthalmologica, vol. 87, no. 8, p. 930-932

Publication date

2009

Keywords

  • Angiogenesis Inhibitors/*administration & dosage
  • Antibodies, Monoclonal/*administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Female
  • Fovea Centralis/*blood supply
  • Humans
  • Injections, Intraocular
  • Middle Aged
  • Retinal Neovascularization/*drug therapy/*etiology
  • Telangiectasis/classification/*complications
  • Vitreous Body

Citation (ISO format)

MAVRAKANAS, Nikolaos et al. Intravitreal ranibizumab and bevacizumab for bilateral subretinal neovascularization secondary to idiopathic juxtafoveal telangiectasia type 2A. In: Acta ophthalmologica, 2009, vol. 87, n° 8, p. 930–932. doi: 10.1111/j.1755-3768.2009.01598.x

Main files (1)

Article

Identifiers

Journal ISSN

1755-375X
541views
0downloads

Technical informations

Creation

23/04/2012 13:24:16

First validation

23/04/2012 13:24:16

Update

14/03/2023 17:26:01

Status update

14/03/2023 17:26:01

Last indexation

29/10/2024 19:34:37
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated